Impact of Policy Changes for Anemia Care in Hemodialysis Examined

WEDNESDAY, May 25, 2022 -- Recommended erythropoietin-stimulating agent dosing changes for anemia care in adults undergoing hemodialysis led to lower erythropoietin-stimulating agent use and lower hemoglobin levels, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news